# Rivaroxaban in Elderly NVAF Patients With or Without Renal Impairment

> **NCT04096547** · — · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 1200 (estimated)

## Conditions studied

- Atrial Fibrillation
- Rivaroxaban
- Elderly
- Renal Insufficiency

## Interventions

- **DRUG:** Rivaroxaban

## Key facts

- **NCT ID:** NCT04096547
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-25
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-08-30
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2020-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04096547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04096547, "Rivaroxaban in Elderly NVAF Patients With or Without Renal Impairment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04096547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*